Not all peptides are cycled the same way. Some require on/off periods to prevent receptor desensitization; others can be used continuously for months; and some (like bioregulators) follow pulsed course protocols. This guide clarifies cycling requirements for each major peptide class.
GH Secretagogues (CJC-1295, Ipamorelin, GHRP series)
GH-stimulating peptides carry a theoretical risk of pituitary desensitization with continuous use — though this is more theoretical than definitively proven in practice.
Standard cycling approaches:
- 5 days on, 2 days off (most common — weekdays only)
- 4 weeks on, 1 week off
- 3 months on, 1 month off for longer cycles
Of these, 5 days on/2 days off is most practical and maintains physiological GH pulsatility.
Healing Peptides (BPC-157, TB-500)
BPC-157 and TB-500 do not stimulate hormone receptors in a way that causes desensitization. Neither suppresses natural hormone production.
BPC-157: Can be used continuously for 8-12 weeks without a break required. Many researchers run 4-8 week courses for injury treatment.
TB-500: Typically cycled as loading (5mg 2x/week for 4-6 weeks) then maintenance (2.5mg 2x/week). No hard evidence of desensitization.
GLP-1 Agonists (Semaglutide, Tirzepatide)
FDA-approved GLP-1 drugs are intended for indefinite chronic use in their approved indications. However, for research protocols, typical durations are:
Acute weight loss phase: 12-24 weeks at escalating doses
Weight maintenance: Continuing at maintenance dose or gradually tapering
Stopping semaglutide causes weight regain in most people — approximately 2/3 of lost weight returns within 1 year after stopping. This is not a safety concern but a consideration for research planning.
Bioregulators (Epithalon, Khavinson Series)
The Khavinson bioregulator class uses a unique cycling protocol designed into the clinical research:
Short-course model: 10-20 consecutive days, 1-2x per year
These are NOT taken daily long-term. The course model provides an initial pulse that triggers gene expression changes that persist for months. Continuous daily use is not the intended protocol and is likely less effective than the short-course approach.
Nootropic Peptides (Semax, Selank)
Intranasal nootropics are generally used in cycles to prevent tolerance:
Standard cycle: 2-4 weeks on, 2-4 weeks off
Some researchers: 5 days on, 2 days off (similar to GH peptides)
Tolerance to Semax's cognitive effects has been reported anecdotally with continuous daily use, supporting cycled approaches.
Key Takeaways
GH secretagogues: 5 days on/2 days off or 3 months on/1 month off. BPC-157/TB-500: 4-12 week courses without mandatory breaks. GLP-1s: intended for continuous use in clinical settings. Bioregulators: 10-20 day course 1-2x/year. Nootropics: 2-4 weeks on/off.